Jbs (JBS) Earnings Analysis
Jbs (JBS) next reports earnings on 2026-08-10, consensus EPS 0.3158 USD. Last quarter (2026-02-11) it missed with EPS 0.39 USD vs 2.26 USD est (-82.7%). It has beaten estimates in 3/6 recent quarters (50%). Trailing P/E 11.87.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does JBS next report earnings?
| Next earnings date | 2026-08-10 |
|---|---|
| Consensus EPS estimate | 0.3158 USD |
| Revenue estimate | 22.98B |
JBS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-11 | 0.39 USD | 2.26 USD | -82.7% | Miss |
| 2025-11-13 | 0.52 USD | 0.507 USD | +2.6% | Beat |
| 2025-08-13 | 0.53 USD | 0.507 USD | +4.5% | Beat |
| 2025-05-15 | 0.2257 USD | 0.4746 USD | -52.4% | Miss |
| 2024-12-31 | 0.1754 USD | 0.2341 USD | -25.1% | Miss |
| 2024-09-30 | 0.3171 USD | 0.2845 USD | +11.5% | Beat |
Beat rate: 3/6 (50%) over reported quarters with consensus data.
JBS valuation and analyst view
| Trailing P/E | 11.87 |
|---|---|
| Trailing EPS | 8.914 USD |
| Price / book | 1.56 |
| Dividend yield | 8.16% |
| Market cap | 26.97B |
| Analyst consensus | Buy (3 buy / 0 hold / 0 sell) |
| Avg price target | 18.5 USD |
Related research pages
Frequently asked questions
When is Jbs (JBS)'s next earnings date?
Jbs is next scheduled to report on 2026-08-10, with a consensus EPS estimate of 0.3158 USD and revenue estimate of 22.98B.
Did JBS beat earnings last quarter?
In its 2026-02-11 report, JBS posted EPS of 0.39 USD versus a 2.26 USD estimate — a miss of 82.7%.
What is JBS's earnings track record?
Over the last 6 reported quarters with consensus data, JBS beat estimates 3 times (50%).
What is JBS's current P/E ratio and EPS?
JBS trades at a trailing P/E of 11.87 on trailing EPS of 8.913803359302703 USD.
What do analysts rate JBS?
Analyst consensus is "Buy" across 3 ratings (0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 18.5 USD.